Sign-up for PARAMOUNT GOLD & SILVER INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Paramount Gold and Silver Corp. investment picks
Inc. (NASDAQ: PRFT) (“Perficient”), a leading information technology
and management consulting firm serving Global 2000 and other large
enterprise customers throughout North America, today announced it has
entered into a purchase agreement to acquire the assets of Zeon
Solutions Incorporated and its subsidiary, Grand River Interactive LLC,
and an Indian affiliate (collectively, “Zeon Solutions”), a $23 million
annual services revenue business and IT consulting firm specializing in
the development, implementation, integration and support of e-commerce
Pfizer Inc. (NYSE:PFE) announced today top-line results from a
double-blind Phase 3 study evaluating pregabalin controlled-release (CR)
formulation in adult patients with postherpetic neuralgia (pain after
shingles or PHN). The results show that pregabalin CR resulted in a
statistically significant positive effect compared to placebo in the
primary endpoint, time to loss of therapeutic response (LTR) in pain
Sealand Natural Resources Inc. (OTCBB: SLNR ),
a new product development company which manufactures, markets and sells
functional beverages (Sealand BIRK ), today announced and welcomes
the appointment of Christine Stavropoulos based in Australia, to the
role of International Corporate Executive Marketing.
Sign-up for SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Petroleo Brasileiro S.A. -- Petrobras and Its Board of Directors and a Lead Plaintiff Deadline of February 6, 2015 -- PBR investment picks
Starwood Hotels & Resorts Worldwide, Inc. (NYSE:HOT) today announced the
launch of its game-changing Aloft® brand in Detroit, following the
completion of an adaptive re-use project that has transformed the
historic David Whitney building.
Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) announced today the
initiation of the first of two planned pivotal phase 3 clinical trials
evaluating the safety and efficacy of 3.0 and 6.0 mg plecanatide,
once-daily oral tablets, for the treatment of irritable bowel syndrome
with constipation (IBS-C). Synergy is also evaluating 3.0 and 6.0 mg
doses of plecanatide in two ongoing pivotal phase 3 trials for chronic
idiopathic constipation (CIC), scheduled to read out top-line results in
second quarter and third quarter 2015.
Terreno Realty Corporation (NYSE:TRNO), an acquirer, owner and
operator of industrial real estate in six major coastal U.S. markets,
acquired an industrial property located in Landover, Maryland on
December 17, 2014 for a purchase price of approximately $31.2 million.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.